Peer Review reports
From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
| Original Submission | ||
|---|---|---|
| 5 Jan 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 9 Jan 2021 | Reviewed | Reviewer Report |
| 26 Jan 2021 | Reviewed | Reviewer Report |
| 1 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
| Resubmission - Version 3 | ||
| 1 Feb 2021 | Submitted | Manuscript version 3 |
| 7 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
| Resubmission - Version 4 | ||
| 7 Feb 2021 | Submitted | Manuscript version 4 |
| 9 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
| Resubmission - Version 5 | ||
| 9 Feb 2021 | Submitted | Manuscript version 5 |
| 24 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
| Resubmission - Version 6 | ||
| 24 Feb 2021 | Submitted | Manuscript version 6 |
| 3 Mar 2021 | Reviewed | Reviewer Report |
| 5 Mar 2021 | Reviewed | Reviewer Report |
| 18 Mar 2021 | Author responded | Author comments - Sung Kyu Hong |
| Resubmission - Version 7 | ||
| 18 Mar 2021 | Submitted | Manuscript version 7 |
| Publishing | ||
| 26 Mar 2021 | Editorially accepted | |
| 5 Apr 2021 | Article published | 10.1186/s12894-021-00827-2 |
You can find further information about peer review here.